BioPharma Dive January 4, 2024
Ned Pagliarulo

The new program, dubbed LillyDirect, will help patients connect with telehealth providers and deliver medicines like the company’s obesity treatment Zepbound.

Dive Brief:

  • Eli Lilly wants to make it easier for people to access its medicines for obesity, diabetes and migraine, announcing Thursday the launch of a website designed to support home delivery of drugs like its in-demand weight loss treatment Zepbound.
  • The company’s new service, dubbed LillyDirect, relies on online pharmacy providers like Eversana and Truepill to deliver prescribed Lilly medicines. A website provides access to telehealth services through which people can consult with an independent physician. If prescribed a Lilly medicine, LillyDirect is also meant to help patients more easily access the company’s savings cards.
  • LillyDirect currently...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Digital Health, Home, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Telehealth
Related Articles:
Healthcare and Life Sciences: Key Insights and Considerations for Stakeholders in 2025
Closing the women’s health gap: Biopharma’s untapped opportunity
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Four Opportunities To Revitalize The US Biomedical Research Enterprise

Share This Article